Clinical trial
Letrozole in the Treatment of Severe and Recurrent Endometriosis
NCT00240942 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00240942 |
|---|---|
| Title | Letrozole in the Treatment of Severe and Recurrent Endometriosis |
| Official title | Letrozole in the Treatment of Severe and Recurrent Endometriosis |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Severe and Recurrent Endometriosis |
| Intervention type | Drug |
| Interventions | Letrozole |
| Enrollment | 40 |
| Start date | Oct 1, 2002 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Oct 18, 2005 |
| Last update posted | Apr 26, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: